Parallel Advisors’s 89bio ETNB Stock Holding History

Parallel Advisors’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25	Closed	-$182	–	3591
2025 Q1	$182	Buy	+25	New	+$219	﹤0.01%	3396

Other funds holding ETNB

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Parallel Advisors's ETNB Position: Q2 2025 in Review

Parallel Advisors sold out of 89bio (ETNB) in Q2 2025, closing a stake of 25 shares — an estimated $182 sold.

Parallel Advisors first reported a position in ETNB in Q1 2025 and held it in 1 quarter. The position peaked at $182 in Q1 2025. 184 funds tracked by Wall St. Rank hold ETNB as of Q2 2025.

Parallel Advisors reported no remaining 89bio position as of Q2 2025 after selling out during the quarter.
Parallel Advisors sold 25 89bio shares in Q2 2025, an estimated $182.
Parallel Advisors first reported a position in 89bio in Q1 2025 and held it in 1 quarter.
Parallel Advisors's 89bio position peaked at $182 in Q1 2025.
184 funds tracked by Wall St. Rank held 89bio as of Q2 2025.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.